Patents by Inventor Rebecca Louise Charlton

Rebecca Louise Charlton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Iminotetrahydropyrimidinone derivatives as plasmepsin V inhibitors
    Patent number: 11136310
    Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Grant
    Filed: November 24, 2016
    Date of Patent: October 5, 2021
    Assignee: UCB Biopharma SRL
    Inventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu
  • IMINOTETRAHYDROPYRIMIDINONE DERIVATIVES AS PLASMEPSIN V INHIBITORS
    Publication number: 20200283416
    Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.
    Type: Application
    Filed: November 24, 2016
    Publication date: September 10, 2020
    Inventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu